The RON receptor tyrosine kinase is activated by macrophage-stimulating protein, which regulates macrophage migration, phagocytosis, and nitric oxide production. We report here the inhibitory effect of RON on lipopolysaccharide (LPS)-induced cyclooxygenase (Cox)-2 expression in mouse macrophages. In RON-expressing macrophages treated with macrophage stimulating protein, LPS-induced prostaglandin E 2 (PGE 2 ) production was significantly reduced. The inhibition was accompanied by reduction of Cox-2 protein and mRNA expression. Transcriptional studies indicated that RON activation inhibits LPS-induced luciferase activity driven by the Cox-2 gene promoter. To determine whether RON activation affects LPS-induced NF-B pathway, which is important for Cox-2 expression. Western blot analyses were performed showing that RON activation inhibits LPS-induced IB␣ degradation. The decreased IB␣ degradation was due to reduced IB␣ phosphorylation at Ser-32 as determined by IB␣ (Ser-32) phosphor-antibody. Moreover, we found that LPS-induced IKK␤ activity, an enzyme responsible for phosphorylation of IB␣, was inhibited upon RON activation. Interestingly, these inhibitory effects were not regulated by RON-mediated phosphatidylinositol-3 kinase. These results suggest that RON activation inhibits LPS-induced macrophage Cox-2 expression. The inhibitory effect is mediated by impairing LPSactivated cascade enzymes that activate NF-B. The inhibition of Cox-2 expression might represent a novel mechanism for the inhibitory functions of RON in vivo against LPS-induced inflammation and septic shock.
the kringle family, which includes HGF and plasminogen (1) (2) (3) . MSP was originally identified by its stimulatory activities on mouse peritoneal resident macrophages (4) . These activities include induction of macrophage shape change, migration, and phagocytosis of complement-coated erythrocytes (1, 3, 4) . However, MSP also inhibits inducible NO production by macrophages stimulated with LPS (5, 6) . MSP is produced mainly by hepatocytes (7) and circulates in blood as a single-chain precursor (8) . Proteolytic conversion is required to activate pro-MSP into the two-chain mature MSP that exerts biological activity (8 -11) . Enzymes including kallikrein, Factor XIA, and Factor XIa in the blood coagulation system activate pro-MSP (9) . Members of the tissue kallikrein family such as nerve growth factor-␥ (NGF-␥) and epidermal growth factor-binding protein (EGF-BP) also cleave pro-MSP (10) . Moreover, proteases on macrophage cell surfaces have the ability to activate pro-MSP (8) .
The receptor for MSP is RON (12, 13) , a receptor tyrosine kinase belonging to the MET proto-oncogene family (14, 15) . The cDNA encoding human RON was originally cloned from skin keratinocytes (14) . The murine homologue of RON, STK, was isolated from bone marrow cells (16, 17) . Mature RON is a 180-kDa heterodimeric protein composed of a 40-kDa ␣-chain and a 140-kDa ␤-chain with intrinsic tyrosine kinase activity (12, 13) . RON is universally present in epithelial cells (18) but expression is restricted in certain types of tissue macrophages including those derived from peritoneal cavity, liver, skin, and bone (19 -22) . Monocytes, alveolar macrophages, and spleen macrophages do not express RON (19) . The partial disruption of the RON gene (knockout, RONϪ/ϩ) significantly increases the inflammatory reactions in vivo after LPS challenge (23) (24) (25) , suggesting that RON plays a critical role in attenuating the extent of inflammatory responses during inflammation and septic shock.
Macrophages produce a variety of inflammatory mediators during inflammation (26, 27) . One of them is PGE (28, 29) . The production of PGE depends on the activity of cyclooxygenases (Cox). Two isoforms of the Cox enzyme, Cox-1 and Cox-2, have been identified, and are coded by two distinct genes (28, 29) . Cox-1 is expressed constitutively in most types of cells and is involved in many physiological functions (28, 30) . In contrast, Cox-2 is an inducible enzyme (24) . Many inflammatory stimuli, including LPS are capable of inducing Cox-2 expression in different cell types, particularly in macrophages (24, 31) . Increased Cox-2 synthesis by tissue macrophages is responsible for the accumulation of large amounts of PGE in local tissues (28) . Secreted PGE, especially PGE 2 , promotes inflammation by increasing vascular permeability and vasodilatation and by directing cell migration into the site of inflammation through then transfected with 3 g of pGL3/Cox2p or pGL3 basic vector using transfection reagent LipofectAMINE (Invitrogen). Cells were also transfected with pRL-SV40 control vector (Promega) to normalize transfection efficiency. Transfected cells were cultured for 16 h and then treated with 1 g/ml LPS in the presence or absence of 5 nM MSP. After an additional 24-h incubation, cells were lysed in lysis buffer and assayed for luciferase activity (38) . The amount of luciferase activity was determined by a Turner Designs Luminometer TD20/20 (Promega).
In Vitro Kinase Assay for IKK␤ Activity-The assay was performed as previously described (36) with slight modifications. Macrophages were treated with LPS or untreated in the presence or absence of 5 nM MSP. IKK␤ was immunoprecipitated from cellular proteins using antibody specific for IKK␤ (Santa Cruz Biotechnology). The samples were suspended in kinase buffer containing 10 M ATP, 3 Ci of [␥ -32 P]ATP and incubated at 34°C for 30 min in the presence of the substrate GSP-IkB␣ (1-54) or mutant GSP-IkB␣ (1-54AA). After the reaction, the protein was separated by SDS-PAGE. Radiolabeled proteins were visualized by autoradiography.
RESULTS

Inhibitory Effect of MSP on LPS-induced Cox-2 Expression in
Mouse Macrophages-In studying the effect of MSP on LPSactivated macrophages, we found that LPS-induced PGE 2 production was significantly inhibited by MSP as determined in the EIA assay. As shown in Fig. 1 , the levels of LPS-induced PGE 2 was dramatically reduced when MSP was included in cell cultures. The amount of PGE 2 in LPS-stimulated cells in the presence of MSP was only about 23% that of cells treated with LPS alone. In Raw264.7 cells expressing the RON mutant M1254T (a constitutively active variant, designated as R-RON-T cells), the levels of LPS-induced PGE 2 were further reduced even without MSP presence. The addition of MSP further inhibited LPS-induced PGE 2 production. The inhibitory effect was observed not only in mouse peritoneal resident macrophages but also in Raw264.7 cells expressing RON (R-RON-8) or R-RON-T. These data suggest that MSP inhibits PGE 2 production by macrophages stimulated with LPS.
To determine whether MSP has the ability to suppress LPSinduced Cox-2 protein expression, Raw264. Fig. 2A) . Similarly, Cox-2 expression was inhibited at both 4 and 8 h in R-RON-T cells that express a constitutively active RON (32) . These results suggest that MSP inhibits LPS-induced Cox-2 expression in RON-expressing Raw264.7 cells.
The time courses of MSP-induced inhibition of Cox-2 expression are shown in Fig. 2B . Both peritoneal resident macrophages and RON-expressing Raw264.7 cells were used in these experiments. MSP inhibited LPS-induced Cox-2 expression in both cells in a time-dependent manner. The inhibitory effect of MSP could be observed as early as 4 h, lasted for up to 18 h, and then gradually diminished at 36 h after LPS stimulation. These results suggest that MSP-induced inhibition of Cox-2 expression is time-dependent, particularly at the early stages of Cox-2 induction. plates. After LPS stimulation, Cox-2 mRNA expression in both macrophages was dramatically increased (Fig. 4, lanes 2 and  5) . However, Cox-2 mRNA induction was significantly inhibited when MSP is included. Only the baseline of Cox-2 mRNA expression was detected. In R-RON-T cells, which express a constitutively active RON mutant, LPS-induced Cox-2 mRNA expression was significantly impaired even without MSP treatment, indicating that RON activation transduces signals that block LPS-induced Cox-2 mRNA expression. These results suggest that MSP not only inhibits Cox-2 protein expression but also blocks LPS-induced Cox-2 mRNA expression.
Inhibitory Effect of MSP on Cox-2 Expression Induced by
Inhibition of LPS-induced Cox-2 Gene Promoter Activities by MSP-To test the hypothesis that MSP-induced inhibition of
Cox-2 mRNA expression is mediated by suppression of Cox-2 promoter activities induced by LPS, luciferase activity driven by the Cox-2 gene promoter was measured in two independent RON-expressing Raw264.7 cell lines. As expected, luciferase activity driven by the Cox-2 gene promoter was barely detectable in cells without stimulation (Fig. 5) . LPS induced high levels of luciferase activities in macrophages transfected with the pGL-3 vector containing the Cox-2 gene promoter. However, LPS-induced luciferase activities were significantly reduced when cells were treated with MSP. The levels of the luciferase activities from MSP-treated R-RON-8 or R-RON-32 cells were only about 30% or 20%, respectively, of those from LPS-stimulated cells. These results suggest that MSP inhibits the Cox-2 gene promoter activity induced by LPS.
Effect of Wortmannin or a ⌬p85 of PI-3 Kinase on MSPinduced Inhibition of Cox-2 Expression-To determine whether
MSP-induced Cox-2 inhibition could be modulated by PI-3 kinase inhibitor, a specific PI-3 kinase inhibitor, wortmannin, was used at optimal concentrations in cell culture in the presence or absence of MSP. All cells were stimulated with LPS. Results are shown in Fig. 6A . Wortmannin alone had no effect on LPS-induced Cox-2 expression. To our surprise, wortmannin did not prevent MSP-induced inhibition of Cox-2 expression induced by LPS. To further study the role of PI-3 kinase, Raw264.7 cells expressing the ⌬p85 of PI-3 kinase (clone R⌬p85-1 and R⌬p85-2) (6) was used. Cells were stimulated with LPS in the presence or absence of MSP as described above. The levels of produced PGE 2 were determined by using the EIA assay. The results (Fig. 6B) show that the levels of MSPinduced PGE 2 inhibition in R-RON-8 cells were comparable to those in R⌬p85-1 or R⌬p85-2 cells. No preventive activities of ⌬p85 of PI-3 kinase in MSP-induced PGE 2 inhibition were observed. These data suggest that blocking endogenous PI-3 kinase activity with the dominant-negative p85 of PI-3 kinase has no effect on RON-mediated inhibition of LPS-induced PGE 2 production.
Inhibitory Effect of MSP on LPS-induced IB␣ Degradation and Phosphorylation-NF-B is normally sequestered in cytoplasm by NF-B inhibitor protein IBs such as IB␣ (39) . LPS stimulation causes degradation of IB␣, which releases NF-B leading to its nuclear translocation (40) . Previous studies have shown that RON activation inhibits LPS-induced NF-B nuclear translocation and impairs its DNA-binding activity (22) , suggesting that MSP affects LPS-induced NF-B activation. Because NF-B activation is required for LPS-induced Cox-2 gene transcription (41, 42), we reasoned that MSP might inhibit LPS-induced degradation of IB␣, which prevents NF-B activation.
To test this hypothesis, the effect of MSP on the levels of IB␣ in LPS-stimulated macrophages was determined. The Experimental conditions were the same as those described in Fig. 1 and 2 . The concentrations of LPS, IFN-␥, or PMA used to stimulate cells was 1 g/ml, 200 units/ml, or 5 nM, respectively. MSP was added simultaneously after initiation of cultures. Cells were collected after a 6-h incubation. Western blot analysis was performed as described in Fig. 2 . Experiments were performed three times with similar results.
FIG. 4.
Inhibition by MSP of LPS-induced Cox-2 mRNA expression in macrophages. Cells were stimulated as described in Fig. 2 . Total RNA was isolated 4 h after treatment. A, Northern blot analysis of Cox-2 mRNA expression using the 32 P-labeled mouse Cox-2 cDNA as the probe. B, the same membrane was reprobed with a labeled ␤-actin cDNA fragment for loading controls.
FIG. 5. Inhibitory effect of MSP on LPS-induced Cox-2 promoter activity. Transient transfection of R-RON-8 or R-RON-32 cells (3 ϫ 10
6 cells/dish) with pGL3 luciferase report vector containing the 0.7-kb mouse Cox-2 gene promoter was performed as described (29, 34) . After transfection, cells were stimulated with 1 g/ml LPS in the presence or absence of 5 nM MSP. The luciferase activity was determined by a TD20/20 Luminometer and normalized for galactosidase activity. In each assay, the luciferase activity induced by LPS was set at 100%. Data are shown as means of three independent experiments. One of three experiments with similar results is shown. results are shown in Fig. 7A . IB␣ was detected in cells without any stimulation. LPS stimulation resulted in a significant decrease of of about 60% the amounts of IB␣ in comparison with those in control cells. However, the presence of MSP prevented the decrease of LPS-induced IB␣ degradation. The levels of IB␣ were comparable to those in control cells. These data suggest that MSP has the ability to prevent the LPS-induced degradation of IB␣ in macrophages, which is consistent with previously reported results showing that MSP inhibits LPSinduced NF-B nuclear translocation (22) .
To determine whether MSP-induced resistance of IB␣ to LPS-induced degradation is caused by the impairment of LPSinduced IB␣ phosphorylation, Western blot analysis was performed using the IB␣ (Ser-32) phosphor-antibody that specifically detects IB␣ phosphorylation. Results are shown in Fig.  7B . As expected, no phosphorylated IB␣ was detected in cells cultured in medium or treated with MSP alone. In LPS-stimulated macrophages, the phosphorylated IB␣ protein was detected. However, when MSP was added into cell cultures in the presence of LPS, the phosphorylation of IB␣ induced by LPS was significantly reduced. Only 35% of the IB␣ protein were detected with phosphorylation at serine residue 32. Similar results were also found when R-RON-32 cells were used (data not shown). Thus, RON activation inhibits LPS-induced phosphorylation of IB␣ at serine residue 32, which prevents the LPS-induced IB␣ degradation as shown in Fig. 7A .
Inhibition by MSP of IKK␤ Activity in LPS-stimulated Macrophages-IKK␤, also known as IKK1, is the intermediate upstream kinase responsible for the phosphorylation of IBs, including IB␣ (40) . Reduced phosphorylation and decreased degradation of IB␣, as shown in Fig. 7, A and B suggest that MSP may affect LPS-induced IKK␤ activity. To test this possibility, we measured the IKK␤ kinase activity in cells stimulated with LPS in the presence or absence of MSP. The results are shown in Fig. 8 . As anticipated, LPS activates IKK␤ with increased kinase activity as shown by the increased phosphorylation of GST-IB␣ but not mutant GST-IB␣ (Fig. 8, lanes  2 and 5) . However, when cells were treated with MSP, the LPS-induced IKK␤ activity was significantly reduced (Fig. 8,  lane 4) . The levels of GST-IB␣ phosphorylation were only about 10% of those without MSP treatment. The reduced GST-IB␣ phosphorylation was not caused by the reduced IKK␤ protein. The amount of IKK␤ loaded into each lane was relatively equal (data not shown). Thus, these results suggest that MSP inhibits IKK␤ activity induced by LPS. This inhibitory effect could lead to stabilization of IB␣ and sequester NF-B in the cytoplasm.
DISCUSSION
The purposes of this investigation were to determine whether MSP-induced RON activation inhibits LPS-induced 10 6 cells/ml ϫ 4 ml) were pretreated with wortmannin (250 nM) or untreated for 30 min. All cells were stimulated with 1 g/ml LPS in the presence or absence of 5 nM MSP. After a 6-h incubation, cells were harvested for Western blot analysis of Cox-2 expression as described in Fig. 2 . B, R-RON-8, R⌬p85-1 or R⌬p85-2 cells were stimulated with LPS in the presence or absence of MSP for 24 h as described in Fig. 1 . The amount of PGE 2 accumulated in culture fluids was determined by using the EIA assay. Each samples were tested in triplicate. Data shown here are from one of three experiments with similar results. Cox-2 expression in macrophages and to study the potential mechanisms underlying this inhibitory effect. MSP regulates macrophage functions through its stimulatory and inhibitory activities (43) . The inhibitory effects include the RON-mediated inhibition of macrophage iNOS expression induced by LPS and inflammatory cytokines (5, 6 ). This effect is considered essential for RON attenuation of inflammatory reactions and septic shock induced by LPS and other agents in vivo (19 -21) . We now provide evidence showing that MSP-induced RON activation also inhibits LPS-induced Cox-2 expression and its associated PGE 2 production in macrophages. As demonstrated by our results, RON activation inhibits LPS-induced PGE 2 production, reduces Cox-2 protein expression, blocks Cox-2 mRNA expression, and suppresses the transcriptional activation of the Cox-2 gene promoter. Moreover, our data demonstrate that the inhibitory effect of MSP is probably mediated by RON-transduced signals that inhibit LPS-stimulated signaling components that in turn activate the NF-B pathway. We also show that LPS-induced phosphorylation and degradation of IB␣ was inhibited upon MSP treatment. Moreover, MSP inhibits the kinase activity of IKK␤, which is the enzyme responsible for the phosphorylation of IB␣ (40) . Because Cox-2 and associated PGE 2 are critical in regulating inflammatory reactions (24, 28) , the inhibition of Cox-2 expression upon RON activation may represent a novel mechanism by which MSP regulates inflammatory activities of macrophages during bacterial infection, tissue injury, and autoimmune responses.
The inhibitory effects of MSP on LPS-induced production of inflammatory mediators by macrophages are largely unknown. To date, NO has been the only known inflammatory mediator reported to be inhibited by MSP in macrophages (5, 29, 37) . Previous studies demonstrated that MSP had no effect in vitro on LPS-induced production of cytokines such as MCP-1 (5). In vivo studies using RON knockout mice further demonstrated that the production of iNOS and NO by macrophages was significantly increased upon LPS challenge, however, LPS-induced IL-6, TNF-␣, IFN-␥, and IL-12 were not affected (23) (24) (25) . From these in vitro and in vivo data, it was concluded that MSP is an endogenous factor that selectively inhibits LPS-induced iNOS synthesis, but not cytokine production (5, 6, (23) (24) (25) . The present finding that RON activation inhibits Cox-2 expression proves that the inhibitory effect of MSP is not limited to LPSinduced iNOS and NO production. Cox-2 and PGE 2 are also targets of MSP. The effects of MSP on iNOS and Cox-2 are particularly interesting with regard to biochemical and biological properties of these two proteins (28, 44) . Both proteins are inducible forms of enzymes that are not expressed in unactivated macrophages. After induction, both enzymes are continuously synthesized, which results in the production of a large amount of NO or PGE 2 (28, 44) . Currently, we do not know why MSP inhibits these two inducible forms of enzymes but has no affect on LPS-induced production of several cytokines such as MCP-1, TNF-␣, and IL-6. Nevertheless, our results indicate that MSP could have broadly inhibitory activities on LPSstimulated macrophages. Thus, it will be of interest in the future to use microarray techniques to analyze the inhibitory effect of MSP at global levels on LPS-induced gene expression in macrophages.
MSP-induced inhibition of Cox-2 expression in LPS-stimulated macrophages seems to act at different levels. We have shown that expression of the Cox-2 protein is significantly inhibited as is evident by Western blot analysis. The levels of Cox-2 protein are only about 20% of those induced by LPS. The Cox-2 mRNA expression induced by LPS was also reduced, as determined by Northern blot techniques. Moreover, we demonstrated that in transient transfection experiments, the LPSinduced luciferase activities driven by the Cox-2 gene promoter were also reduced. We cannot exclude the possibility that MSPinduced RON activation transduces signals that may affect Cox-2 expression by increasing the degradation of the Cox-2 protein, reducing the stability of the Cox-2 mRNA, and blocking the Cox-2 gene promoter activity. Such inhibitory effects are very similar to those observed in MSP-mediated inhibition of iNOS expression (5, 6, 22) . MSP suppresses iNOS protein expression, inhibits iNOS mRNA translation, and affects iNOS gene transcription (5, 6, 22) . It is likely that decreased Cox-2 expression at protein and mRNA levels is caused by the inhibition of Cox-2 gene promoter activity, which blocks Cox-2 gene transcription.
Signaling pathways involved in LPS-induced Cox-2 expression have been studied extensively (37, 42, (43) (44) (45) . It is now known that Cox-2 gene transcription is activated through different pathways, including the NF-B pathway, the mitogenactivated protein kinase, and others (34, (43) (44) (45) . These pathways act in unison to achieve the optimal levels of Cox-2 gene transcription activation. The roles of NF-B pathways in LPSinduced Cox-2 expression are controversial. Studies of transcriptional activation of the Cox-2 gene promoter have indicated that the NF-B-binding sites in the promoter regions are not required for the optimal Cox-2 reporter gene expression (34) . However, the majority of reports show that LPS-activated NF-B is required for Cox-2 expression (39, (45) (46) (47) . Activation of NF-B is associated with increased Cox-2 expression (41). Blocking NF-B activities by chemical inhibitors such as pyrrolidine dithiocarbamate decreased Cox-2 expression (46). Suppression of NF-B translocation to the nucleus by synthetic peptide inhibitors also blocks LPS-induced Cox-2 expression (47) . Recent studies further demonstrated that NF-B cooperates with other transcription factors in induction of Cox-2 gene transcription (47) . Thus, the NF-B pathway is necessary and important in LPS-induced Cox-2 expression in macrophages.
NF-B activation is tightly regulated by inhibitor protein IBs, (IB␣, IB␤, and IB⑀) that sequester NF-B in the cytoplasm of unstimulated cells (39) . Phosphorylation of serine residues in IBs, particularly in IB␣, initiates polyubiquitination and subsequent degradation of IB␣, which releases NF-B into the nucleus for DNA binding (39, 40) . The phosphorylation of IB␣ is mediated by the large IKK complex (39, 40) . LPS is known to activate IKK, which phosphorylates IB␣ (46) . The IKK complex contains two closely related kinase subunits, IKK␣ and IKK␤, and two accessory proteins, IKK␥ and IKAP (39, 40, 48) . Recent studies have shown that IKK␤ is 6 cells/ ml ϫ 4 ml) were stimulated with 1 g/ml LPS in the presence or absence of 5 nM MSP for 60 min. The IKK␤ protein was immunoprecipitated from cell lysates (3 mg of protein/sample) using the specific antibody. The kinase assay was performed as detailed under "Experimental Procedures." The phosphorylated GST-IB␣ was detected by autoradiography after SDS-PAGE. The last lane on the right is a negative control of mutant GST-IB␣ as substrate.
the kinase subunit responsible for the phosphorylation of IB␣ in LPS-activated macrophages (48) .
Previous studies have found that RON activation inhibits LPS-induced nuclear translocation of NF-B and its DNA-binding activity to NF-B-binding sites (22) . The data from our present study confirm these findings. We showed that MSP inhibits LPS-induced phosphorylation and degradation of IB␣. We also found that IKK␤ activity was significantly reduced as determined in the in vitro kinase assay. These results suggest that RON activation impairs LPS-induced activation of the NF-B pathway. Thus, the inhibition of NF-B could be one of the mechanisms by which RON activation inhibits Cox-2 expression. Considering the fact that the blocking of NF-B is also involved in RON-mediated inhibition of iNOS expression, it is speculated that RON activation might utilize the same mechanism to regulate the LPS-induced NF-B pathway, which blocks LPS-induced Cox-2 expression.
One of the interesting findings in this study is that PI-3 kinase is not involved in RON-mediated inhibition of Cox-2 expression in macrophages. PI-3 kinase is a lipid enzyme known for its role in regulating macrophage migration, differentiation, survival, and inflammatory mediator production (49) . We have shown previously that RON activation stimulates PI-3 kinase and causes its p85 subunit to interact with activated RON (50) . More importantly, suppressing PI-3 kinase prevents RON-mediated inhibition of NO production induced by LPS and inflammatory cytokines (6) , suggesting that PI-3 kinase is one of the effector molecules responsible for RONmediated inhibition of iNOS expression. However, our present study, using wortmannin and the dominant-negative p85 of PI-3 kinase suggests that RON-activated PI-3 kinase is not involved in MSP-induced Cox-2 inhibition. Studies are currently under way to determine the molecules involved in MSPinduced inhibition of Cox-2 expression in LPS-stimulated macrophages.
